Jorn Fierstra1, Bas van Niftrik2, Marco Piccirelli3, Jan Karl Burkhardt2, Athina Pangalu3, Roman Kocian4, Antonios Valavanis3, Michael Weller5, Luca Regli2, Oliver Bozinov2. 1. Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland. Electronic address: jorn.fierstra@usz.ch. 2. Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland. 3. Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland. 4. Department of Neuro-anesthesia, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland. 5. Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.
Abstract
INTRODUCTION: Current MRI sequences are limited in identifying brain areas at risk for high grade glioma recurrence. We employed intraoperative 3-Tesla functional MRI to assess cerebrovascular reactivity (CVR) after high-grade glioma resection and analyzed regional CVR responses in areas of tumor recurrence on clinical follow-up imaging. METHODS: Five subjects with high-grade glioma that underwent an intraoperative Blood Oxygen-Level Dependent (BOLD) MRI CVR examination and had a clinical follow-up of at least 18months were selected from a prospective database. For this study, location of tumor recurrence was spatially matched to the intraoperative imaging to assess CVR response in that particular area. CVR is defined as the percent BOLD signal change during repeated cycles of apnea. RESULTS: Of the 5 subjects (mean age 44, 2 females), 4 were diagnosed with a WHO grade III and 1 subject with a WHO grade IV glioma. Three subjects exhibited a tumor recurrence on clinical follow-up MRI (mean: 15months). BOLD CVR measured in the spatially matched area of tumor recurrence was on average 94% increased (range-32% to 183%) as compared to contralateral hemisphere CVR response, 1.50±0.81 versus 1.03±0.46 respectively (p=0.31). CONCLUSION: For this first analysis in a small cohort, we found altered intraoperative CVR in brain areas exhibiting high grade glioma recurrence on clinical follow-up imaging.
INTRODUCTION: Current MRI sequences are limited in identifying brain areas at risk for high grade glioma recurrence. We employed intraoperative 3-Tesla functional MRI to assess cerebrovascular reactivity (CVR) after high-grade glioma resection and analyzed regional CVR responses in areas of tumor recurrence on clinical follow-up imaging. METHODS: Five subjects with high-grade glioma that underwent an intraoperative Blood Oxygen-Level Dependent (BOLD) MRI CVR examination and had a clinical follow-up of at least 18months were selected from a prospective database. For this study, location of tumor recurrence was spatially matched to the intraoperative imaging to assess CVR response in that particular area. CVR is defined as the percent BOLD signal change during repeated cycles of apnea. RESULTS: Of the 5 subjects (mean age 44, 2 females), 4 were diagnosed with a WHO grade III and 1 subject with a WHO grade IV glioma. Three subjects exhibited a tumor recurrence on clinical follow-up MRI (mean: 15months). BOLD CVR measured in the spatially matched area of tumor recurrence was on average 94% increased (range-32% to 183%) as compared to contralateral hemisphere CVR response, 1.50±0.81 versus 1.03±0.46 respectively (p=0.31). CONCLUSION: For this first analysis in a small cohort, we found altered intraoperative CVR in brain areas exhibiting high grade glioma recurrence on clinical follow-up imaging.
Authors: Giovanni Muscas; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Giuseppe Esposito; Luca Regli; Jorn Fierstra Journal: Acta Neurochir Suppl Date: 2021
Authors: Vittorio Stumpo; Martina Sebök; Christiaan Hendrik Bas van Niftrik; Katharina Seystahl; Nicolin Hainc; Zsolt Kulcsar; Michael Weller; Luca Regli; Jorn Fierstra Journal: MAGMA Date: 2021-12-07 Impact factor: 2.310
Authors: Peiying Liu; Dengrong Jiang; Marilyn Albert; Christopher E Bauer; Arvind Caprihan; Brian T Gold; Steven M Greenberg; Karl G Helmer; Kay Jann; Gregory Jicha; Pavel Rodriguez; Claudia L Satizabal; Sudha Seshadri; Herpreet Singh; Jeffrey F Thompson; Danny J J Wang; Hanzhang Lu Journal: Neuroimage Date: 2021-11-23 Impact factor: 7.400
Authors: Vittorio Stumpo; Lelio Guida; Jacopo Bellomo; Christiaan Hendrik Bas Van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra Journal: Cancers (Basel) Date: 2022-03-05 Impact factor: 6.639
Authors: Peiying Liu; Zachary Baker; Yue Li; Yang Li; Jiadi Xu; Denise C Park; Babu G Welch; Marco Pinho; Jay J Pillai; Argye E Hillis; Susumu Mori; Hanzhang Lu Journal: PLoS One Date: 2022-09-28 Impact factor: 3.752
Authors: Martina Sebök; Christiaan Hendrik Bas van Niftrik; Giovanni Muscas; Athina Pangalu; Katharina Seystahl; Michael Weller; Luca Regli; Jorn Fierstra Journal: Neurooncol Adv Date: 2021-03-30
Authors: Martina Sebök; Christiaan Hendrik Bas van Niftrik; Matthias Halter; Aimee Hiller; Katharina Seystahl; Athina Pangalu; Michael Weller; Christoph Stippich; Luca Regli; Jorn Fierstra Journal: Cerebellum Date: 2020-12 Impact factor: 3.847